SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-20-126182
Filing Date
2020-04-29
Accepted
2020-04-29 16:13:57
Documents
5
Period of Report
2020-06-26
Effectiveness Date
2020-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A d886790ddef14a.htm DEF 14A 636808
2 GRAPHIC g886790g01b58.jpg GRAPHIC 168632
3 GRAPHIC g886790g02a34.jpg GRAPHIC 191320
4 GRAPHIC g886790g67c71.jpg GRAPHIC 8721
5 GRAPHIC g886790g97s65.jpg GRAPHIC 57988
  Complete submission text file 0001193125-20-126182.txt   1225889
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36276 | Film No.: 20830452
SIC: 2834 Pharmaceutical Preparations